Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 1376-1382, 2013.
Artigo em Chinês | WPRIM | ID: wpr-259466

RESUMO

Hyaluronic acid (HA) as anticancer drug carrier has become the new hot point in the field of tumor-targeted drugs delivery system in recent years. Tumor therapeutic agents could be transmitted into cells because of hyaluronic acid innate ability to recognize specific cellular receptors that overexpressed on tumor cells surface. This review introduces the basic properties and physiology foundation of hyaluronic acid. Recent research developments based on different forms of HA tumor-targeted drugs delivery systems are reviewed in particular.


Assuntos
Animais , Humanos , Antineoplásicos , Química , Usos Terapêuticos , Portadores de Fármacos , Sistemas de Liberação de Medicamentos , Ácido Hialurônico , Química , Estrutura Molecular , Nanopartículas , Neoplasias , Tratamento Farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA